The colocalization of PAP (green) and GAD65/67 (red) was seen in several areas of brain.

<p>In cerebral Purkinje cells (A–C), strong colocalization was seen especially in the axon hillock of the neuron (small picture in C; yellow color and white arrows depicting the colocalization). Similarly, PAP was present in GABAergic neurons in prefrontal cortex (PFC; infralimbic cortex) (D–F). Scale bars are 10 µm.</p

Immunostaining of Snapin in various brain areas of WT and PAP^−/− mice.

<p>In the PAP^−/− mouse, Snapin (red) is localized more diffusely in the cell soma (B, D, F). Cellular localization of Snapin in WT mouse is more vesicular-like (A, C, E). Scale bar is 10 µm in all figures. M1 - primary motor cortex; SN - substantia nigra.</p

Immunofluorescent colocalization stainings of TMPAP and synaptic vesicle associated proteins.

<p>TMPAP (green) is colocalized with a presynaptic marker, synaptophysin (red) (A–C; yellow color and white arrows depicting the colocalization). PAP was seen in vesicle-like structures that had strong colocalization with Snapin (D–F). Small picture is a magnification from panel C, depicting the colocalization. Moreover, largest PAP-immunoreactive structures had a colocalization with multivesicular bodies (MVB, red; G–I). All pictures are from striatum. Scale bars are 10 µm in A–C and G–I, and 3 µm in D–F.</p

TMPAP is expressed in the mouse brain and colocalizes with GABAergic marker, GAD 65/67.

<p>Representative confocal images depict intense TMPAP (brown color) expression in molecular cell layer (M) and Purkinje cells (P) of cerebellum (Panel A), in substantia nigra pars reticulata (SNpr; Panel B), in red nucleus (RN; Panel C) and in oculomotor nucleus (O; Panel C). Small picture in Panel B depicts the TMPAP staining of the substantia nigra in PAP<i>^−/−</i> mouse. TMPAP (green) was colocalized with GABAergic marker (red) in medium spiny neurons of striatum (Panels D-G, yellow color and white arrows indicating the colocalization) and in SNpr (Panels H–K). Colocalization was evident also in GABAergic neurons of hippocampus CA1 (Panels L–O). DAPI (blue color) was used as a nuclear marker. Scale bars are 500 µm in Panels A–C, and 10 µm in panels D–O.</p

Anatomical, neurochemical and behavioral characterization of mice deficient in prostatic acid phosphatase (PAP).

<p><b>ABBREVIATIONS:</b> NSD - no significant difference; ↑- increased; DA - dopamine; DOPAC - 3,4-Dihydroxyphenylacetic acid; GABAA - GABAA receptor; mIPSC - miniature inhibitory postsynaptic current; LORR - loss of righting reflex; PPI - prepulse inhibition; EPM - elevated plus-maze; OF - open field; LD - light-dark box; RR - rota-rod; BW - beam walking; FST - forced swim test; TST - tail suspension test; FC - fear conditioning; RI - resident-intruder test; WM - water maze.</p

The frequency of spontaneous hippocampal mIPSCs is increased in PAP^−/− mice.

<p>(A) Sample traces of mIPSC from WT and PAP<i>^−/−</i> mice (P14–P18). (B) The mIPSC frequency in the PAP<i>^−/−</i> mice was higher (<i>p</i> = 0.003) compared to WT mice. The graph shows the cumulative distribution of the events. (C) Sample traces from 8 averaged mIPSCs from PAP<i>^−/−</i> and WT mice. (D) There were no differences in the amplitude in mIPSCs recorded from WT and PAP<i>^−/−</i> mice. The graph shows the cumulative distribution of the amplitudes.</p

Dopamine synthesis is augmented in the striatum of PAP<i>^−/−</i> mice.

<p>(A) Tissue levels of DA are similar in WT and PAP<i>^−/−</i> mice. (B) Level of the principal metabolite of DA, DOPAC, is elevated in the PAP<i>^−/−</i> mice, and also the DOPAC/DA ratio is elevated (C). (D) Accumulation of L-DOPA is greater in PAP^−/− mice than WT mice 30 min after administration of a blocker of L-amino acid decarboxylase, indicating increased DA synthesis. The data is expressed as mean±S.E.M.; black bars represent WT, grey bars PAP^−/− mice; *<i>p</i><0.05, two tailed t-test (monoamines) or repeated measures ANOVA (microdialysis).</p

Lateral ventricles volume is enlarged in PAP^−/− mice.

<p>Lateral ventricles (right and left ventricles) volume is significantly larger (**<i>p</i><0.01) in both young and old PAP<i>^−/−</i> mice compared to corresponding WT mice. (A) T2-weighted images from young (2 months) and old (12 months) WT and PAP<i>^−/−</i> mice. Plot of (B) lateral ventricle volumes and (C) total brain size for WT and PAP<i>^−/−</i> mice. The data is expressed as mean±S.E.M.</p

Characterization of dopaminergic transmission in PAP^−/− mice by microdialysis.

<p>(A) There is no difference in haloperidol (0.2 mg/kg) -induced dopamine release between PAP^−/− and WT mice. (B) Adenosine A₁-agonist GR79236X (1 mg/kg) and A₁-antagonist 8-CPT (300 µM in dialysis fluid) significantly decreased and increased the release of dopamine, respectively (repeated measures ANOVA) but there was no difference in the magnitude of response between the genotypes. (C) There is no significant difference in potassium–induced DA release between the genotypes, but amphetamine induces DA release significantly faster. The data is expressed as mean±S.E.M.; black squares represent WT, grey dots PAP<i>^−/−</i> mice.</p

PAP^−/− mice show increased anxiety, disrupted PPI, augmented locomotor response to amphetamine and increased tolerance to diazepam-induced loss of righting reflex.

<p>(A) PAP^−/− mice spent less time in open arms of the elevated plus maze, and more time in closed arms than WT mice. The ratio of open arm entries was lower in PAP^−/− mice. (B) PAP^−/− mice have reduced PPI of the acoustic startle reflex. PPI was enhanced by treatment with haloperidol. (C) Amphetamine-induced locomotor activity was significantly increased in PAP^−/− mice compared to WT mice (p = 0.0001), whereas the effect of MK-801 (D) was similar between the genotypes. (E) PAP^−/− mice displayed shorter duration of loss of righting reflex after treatment with high dose of diazepam. The data is expressed as mean±S.E.M.; black bars/squares represent WT, grey bars/dots PAP^−/− mice; *<i>p</i><0.05 between the genotypes.</p